Scopus BioPharma (formerly known as Project18) is a biopharmaceutical company developing therapeutics targeting diseases with unmet medical needs. Its lead drug candidate is a targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company also develops additional new chemical entities to treat other serious diseases, including systemic sclerosis.